Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05948657 · ClinicalTrials.gov registry record · NA

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

A NA study of Prostate Cancer, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
4
Study locations

NCT05948657 is a NA study of Prostate Cancer that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05948657, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
4
Study locations

Study Summary

This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • DIAGNOSTIC_TEST PSMA-PET CT

Study Locations (4)

California

  • UCLA - Los Angeles
  • UCSF - San Francisco

New York

  • Weill Cornell Medicine - New York Presbyterian Hospital - New York

Ohio

  • Case Western University Hospitals - Cleveland

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-02-26
Est. Completion 2028-12
Phase NA

Sponsor

Weill Medical College of Cornell University

701 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05948657

The ClinicalTrials.gov registry entry for NCT05948657 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (67% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which PSMA-PET CT is the first listed.

NCT05948657 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT05948657 about?

NCT05948657 is a clinical study titled "Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr". This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.

What is the current status of trial NCT05948657?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-02-26. Estimated completion is 2028-12.

What conditions does trial NCT05948657 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05948657?

The interventions under investigation include: PSMA-PET CT (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05948657?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05948657 being conducted?

This trial has 4 study locations across California, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.